Researchers from St. Jude Children's and the German Cancer Research Center used methylation and gene expression analyses to uncover the subtypes.
The Belgian cancer diagnostics firm will provide the lab with access to its OncoDeep DX Plus and Clinical Plus services.
Both studies found that about 40 percent of pediatric cancer patients have mutations with potential clinical significance, either for diagnosis or treatment.
The researchers performed targeted sequencing using Thermo Fisher Scientific's Oncomine Comprehensive Panel and the Ion Torrent PGM or Proton.
The partners will develop an NGS panel for solid and liquid tumors for use in personalized oncology.
Reimbursement from private insurers continues to grow, with United Healthcare recently saying it will cover molecular profiling for stage IV non-small cell lung cancer patients.
Under the terms of the agreement, N-of-One will provide clinical interpretation services for samples sequenced on a 50-gene hot-spot solid tumor panel.
The combined offering will enable customers to assess health outcomes and therapy effectiveness at the patient-anonymous level.
The Broad will partner with Dana-Farber/Harvard Cancer Center and Memorial Sloan Kettering Cancer Center on a large tumor sequencing study.
During a conference call, management discussed new commercial initiatives and investments, reimbursement progress, and its partnership with Roche.
University of Idaho researchers model the scientific discovery process to examine the link between reproducibility and scientific truth.
A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.
Relocating USDA agencies outside of Washington, DC, may make them less effective, critics of the move tell NPR.
In PLOS this week: genes that help Borrelia burgdorferi survive in ticks, CiliaCarta collection of about 1,000 suspected cilia genes, and more.